150 related articles for article (PubMed ID: 16808548)
1. Desmopressin : safety considerations in patients with chronic renal disease.
Sica DA; Gehr TW
Drug Saf; 2006; 29(7):553-6. PubMed ID: 16808548
[No Abstract] [Full Text] [Related]
2. Desmopressin 30 years in clinical use: a safety review.
Vande Walle J; Stockner M; Raes A; Nørgaard JP
Curr Drug Saf; 2007 Sep; 2(3):232-8. PubMed ID: 18690973
[TBL] [Abstract][Full Text] [Related]
3. Desmopressin (Nocdurna and Noctiva) for nocturnal polyuria.
Med Lett Drugs Ther; 2019 Mar; 61(1568):46-48. PubMed ID: 31022158
[No Abstract] [Full Text] [Related]
4. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations.
Kim RJ; Malattia C; Allen M; Moshang T; Maghnie M
Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():115-23. PubMed ID: 16456490
[TBL] [Abstract][Full Text] [Related]
5. Severe Hyponatremia After Desmopressin Diacetate Arginine Vasopressin Infusion in an Older Woman.
Yalcin A; Silay K; Yilmaz T; Atmis V; Atli T
J Am Geriatr Soc; 2016 May; 64(5):1138-9. PubMed ID: 27225368
[No Abstract] [Full Text] [Related]
6. Role of Desmopressin in the Critical Care Setting.
Goad N; Levesque M
AACN Adv Crit Care; 2020 Mar; 31(1):5-11. PubMed ID: 32168509
[No Abstract] [Full Text] [Related]
7. [Hyponatremic coma induced by desmopressin infusion in a woman with von Willebrand's disease].
Brillouet-Banchereau AC; Winnock S; Maurette P
Ann Fr Anesth Reanim; 2009 Oct; 28(10):909-10. PubMed ID: 19836189
[No Abstract] [Full Text] [Related]
8. Venous thrombosis of free flap immediately after intravenous application of desmopressin.
Ensat F; Wakolbinger R; Schubert HM; Moser G; Hladik M; Wechselberger G
Microsurgery; 2013 Jan; 33(1):79-80. PubMed ID: 22976561
[No Abstract] [Full Text] [Related]
9. Effect on early graft function of high-dose desmopressin in transplant recipients with bleeding disorders.
Tramma D; O'Brien C; Hulton SA
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):364-5. PubMed ID: 23538365
[No Abstract] [Full Text] [Related]
10. Gender difference in antidiuretic response to desmopressin.
Juul KV; Klein BM; Sandström R; Erichsen L; Nørgaard JP
Am J Physiol Renal Physiol; 2011 May; 300(5):F1116-22. PubMed ID: 21367921
[TBL] [Abstract][Full Text] [Related]
11. Desmopressin acetate nasal spray for adults with nocturia.
Cohn JA; Kowalik CG; Reynolds WS; Kaufman MR; Milam DF; Dmochowski RR; Wein AJ
Expert Rev Clin Pharmacol; 2017 Dec; 10(12):1281-1293. PubMed ID: 29048257
[TBL] [Abstract][Full Text] [Related]
12. Clinical study shows improved absorption of desmopressin with novel formulation.
Fransén N; Bredenberg S; Björk E
Pharm Res; 2009 Jul; 26(7):1618-25. PubMed ID: 19296208
[TBL] [Abstract][Full Text] [Related]
13. [Desmopressin therapy of nocturia in elderly patients may contribute to severe hyponatraemia].
Sivalingam S; Sonne MP; Eldrup E
Ugeskr Laeger; 2018 Jul; 180(30):. PubMed ID: 30037383
[TBL] [Abstract][Full Text] [Related]
14. Re: desmopressin toxicity due to prolonged half-life in 18 patients with nocturnal enuresis. J. L. Dehoorne, A. M. Raes, E. van Laecke, P. Hoebeke and J. G. Vande Walle J Urol 2006; 176: 754-758.
Nørgaard JP; Osterberg O; Holdrup L
J Urol; 2007 Mar; 177(3):1204; author reply 1204-5. PubMed ID: 17296451
[No Abstract] [Full Text] [Related]
15. Severe hyponatremia due to desmopressin.
Kelleher HB; Henderson SO
J Emerg Med; 2006 Jan; 30(1):45-7. PubMed ID: 16434334
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and Pharmacodynamic Properties of a Micro-Dose Nasal Spray Formulation of Desmopressin (AV002) in Healthy Water-Loaded Subjects.
Andersson KE; Longstreth J; Brucker BM; Campeau L; Cheng L; Francis L; Fein S
Pharm Res; 2019 Apr; 36(6):92. PubMed ID: 31037429
[TBL] [Abstract][Full Text] [Related]
17. Severe hyponatraemia associated with desmopressin nasal spray to treat clozapine-induced nocturnal enuresis.
Sarma S; Ward W; O'Brien J; Frost AD
Aust N Z J Psychiatry; 2005 Oct; 39(10):949. PubMed ID: 16168026
[No Abstract] [Full Text] [Related]
18. Pharmacists have a key role in raising awareness around risks of intranasal desmopressin.
Kwok J; Gue D; Curtis J; Jackson S
J Am Pharm Assoc (2003); 2014; 54(5):460-2. PubMed ID: 25216872
[No Abstract] [Full Text] [Related]
19. Re: Safety and Efficacy of Desmopressin for the Treatment of Nocturia in Elderly Patients: A Cohort Study.
Griebling TL
J Urol; 2015 Sep; 194(3):732. PubMed ID: 26292871
[No Abstract] [Full Text] [Related]
20. Clinical observations of the effect of antidiuretic hormone on nocturia in elderly men.
Ho DR; Lin WY; Wu CF; Shee JJ; Huang YC; Chen CS
BJU Int; 2005 Dec; 96(9):1310-3. PubMed ID: 16287451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
